Category Archives: Clinical Trials

Online Study: “Understanding IBS Patient Self-Management Strategies and their Relation to Outcomes”, Icahn-Mount Sinai, September 2018

The following study is currently seeking adults 18-65 years old who are fluent in English and have a diagnosis of IBS. The primary investigator is Laurie Keefer, PhD of Icahn Mount Sinai Medical School in New York, in cooperation with the Center for Psychosocial Research in GI at Northwestern University in Chicago. IBS Impact received …

Continue reading

Online Study: Cognitive Mediators of Bowel Discomfort Validation Study, Swinburne University, Australia, June 2018

The following study currently seeking men and women at least 18 years old in any country with chronic gastrointestinal conditions is a followup to an online study posted here on August 12, 2017.  The 2017 study is now closed to new volunteers. The current study has received institutional ethical approval. All information available to IBS …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2018

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, at least 25 million and perhaps up to 58 million women, men and children in the United States and anywhere from 9-23% of the population in different countries on every continent of the world.  In the U.S, this prevalence exceeds that of diabetes, chronic …

Continue reading

Registries for Irritable Bowel Syndrome (IBS) Research Volunteers Created in the United Kingdom and Australia

In recent weeks, IBS Impact has learned that two separate entities, the County Durham and Darlington NHS Foundation Trust in the United Kingdom, and Macquarie University Faculties of Human Sciences and Medicine and Health Sciences in Sydney, Australia have established new, secure registries for those who are interested in volunteering for research studies. The Macquarie …

Continue reading

Online Study: Cognitive Mediators of Bowel Discomfort, Swinburne University, Australia, August 2017

The following study currently seeking men and women at least 18 years old with gastrointestinal conditions was received directly from the research team and is posted at their invitation. We are advised that the study has received institutional ethical approval. All information available to IBS Impact is below and at the study link. Please address …

Continue reading

Online Study: Thought Impact Scale, University of North Carolina, May 2017

The following online study conducted by Olafur Palsson, PsyD, psychologist, professor and researcher at the University of North Carolina Center for Functional GI and Motility Disorders, Chapel Hill, North Carolina, was received recently via social media. Dr. Palsson is a leading international researcher of IBS and its psychological aspects. The current study is not specific …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2017

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, at least 25 million and perhaps up to 58 million women, men and children in the United States and anywhere from 9-23% of the population in different countries on every continent of the world.  In the U.S, this prevalence exceeds that of diabetes, chronic …

Continue reading

Online Clinical Trial: The Effects of Food on IBS and IBD, Northwestern and Rush Universities, July 2016

The following online clinical trial seeking adult volunteers with either irritable bowel syndrome (IBS) or any form of inflammatory bowel disease (IBD) was received recently via the social media of Oak Park Behavioral Medicine located in suburban Chicago. Oak Park Behavioral Medicine is a private practice partnership of psychologist, Tiffany Taft, PsyD and social worker, Stephanie Horgan, …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2016

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, at least 25 million and perhaps up to 58 million women, men and children in the United States and anywhere from 9-23% of the population in different countries on every continent of the world.  In the U.S, this prevalence exceeds that of diabetes, chronic …

Continue reading

Clinical Trial: Fecal Microbiota Transplant for Adult IBS-D, Montefiore Medical Center, New York, February 2016

Montefiore Medical Center, a major academic medical center in Bronx, New York (New York City) is currently recruiting men and women, ages 19-65 with physician-diagnosed, (Rome III criteria) irritable bowel syndrome with diarrhea (IBS-D) for a clinical trial to determine the possible  safety, feasibility and effectiveness of fecal microbiota transplantation for IBS-D. Potential volunteers must …

Continue reading